X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1815) 1815
Publication (247) 247
Newsletter (174) 174
Book Chapter (8) 8
Book Review (7) 7
Conference Proceeding (7) 7
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1662) 1662
glioblastoma - enzymology (992) 992
index medicus (900) 900
brain neoplasms - enzymology (816) 816
oncology (751) 751
glioblastoma (708) 708
animals (701) 701
cell line, tumor (667) 667
glioblastoma - pathology (595) 595
brain neoplasms - pathology (518) 518
cancer (510) 510
glioblastoma multiforme (459) 459
mice (415) 415
female (409) 409
male (375) 375
glioblastoma - genetics (369) 369
glioma - enzymology (327) 327
expression (322) 322
glioma (318) 318
apoptosis (317) 317
brain neoplasms - genetics (307) 307
cell biology (297) 297
glioblastoma - drug therapy (286) 286
gliomas (278) 278
middle aged (256) 256
tumors (251) 251
biochemistry & molecular biology (242) 242
adult (237) 237
tumor cells, cultured (232) 232
research (219) 219
brain neoplasms - drug therapy (217) 217
glioma - pathology (215) 215
glioblastoma - metabolism (206) 206
aged (197) 197
phosphorylation (195) 195
astrocytoma - enzymology (194) 194
brain tumors (194) 194
signal transduction (189) 189
neurosciences (181) 181
mice, nude (180) 180
clinical neurology (178) 178
transfection (177) 177
apoptosis - drug effects (171) 171
gene expression regulation, neoplastic (171) 171
immunohistochemistry (169) 169
antineoplastic agents - pharmacology (167) 167
proteins (158) 158
activation (157) 157
prognosis (157) 157
growth (155) 155
rats (155) 155
temozolomide (149) 149
gene expression (147) 147
neoplasm invasiveness (147) 147
cell proliferation - drug effects (146) 146
genetic aspects (146) 146
article (145) 145
brain neoplasms - metabolism (145) 145
cell proliferation (145) 145
mutation (144) 144
brain cancer (138) 138
brain-tumors (134) 134
survival (133) 133
cells (132) 132
in-vivo (132) 132
glioma - genetics (129) 129
blotting, western (126) 126
kinases (126) 126
invasion (125) 125
analysis (121) 121
in-vitro (121) 121
signal transduction - drug effects (121) 121
brain (120) 120
multidisciplinary sciences (120) 120
research article (119) 119
inhibition (117) 117
medicine (115) 115
time factors (115) 115
glioblastoma cells (114) 114
care and treatment (113) 113
dacarbazine - analogs & derivatives (112) 112
chemotherapy (111) 111
pathology (111) 111
enzyme inhibitors - pharmacology (110) 110
genetics & heredity (110) 110
physiological aspects (109) 109
xenograft model antitumor assays (109) 109
angiogenesis (108) 108
enzymes (108) 108
glioblastoma - therapy (108) 108
glioblastoma-multiforme (107) 107
health aspects (107) 107
brain neoplasms - therapy (99) 99
medicine, research & experimental (99) 99
proto-oncogene proteins c-akt - metabolism (95) 95
pharmacology & pharmacy (93) 93
astrocytoma - pathology (92) 92
malignant glioma (92) 92
development and progression (91) 91
enzyme activation (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1937) 1937
German (19) 19
French (10) 10
Russian (10) 10
Japanese (9) 9
Italian (3) 3
Chinese (2) 2
Spanish (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2192 - 2197
Purpose Standard therapy for glioblastoma (GBM) is temozolomide (TMZ) administration, initially concurrent with radiotherapy (RT), and subsequently as... 
MALIGNANT GLIOMA | TUMOR PROGRESSION | SPECTROSCOPY | ONCOLOGY | PHASE-II | RADIOTHERAPY | MULTIFORME | CEREBRAL GLIOMAS | BRAIN | CONCURRENT | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Glioblastoma - enzymology | Humans | Middle Aged | Male | Glioblastoma - radiotherapy | Glioblastoma - genetics | Time Factors | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Brain Diseases - etiology | Genetic Predisposition to Disease | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Brain Neoplasms - genetics | Brain Diseases - enzymology | Brain Neoplasms - drug therapy | Radiation Injuries - enzymology | Disease Progression | Radiation Injuries - etiology | Magnetic Resonance Imaging | Glioblastoma - pathology | Radiation Injuries - pathology | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Brain Diseases - genetics | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Necrosis | Patient Selection | DNA Methylation | Radiation Injuries - genetics | Tumor Suppressor Proteins - genetics | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Adult | Female | Retrospective Studies | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Brain Neoplasms - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Gene Expression Regulation, Enzymologic | DNA Modification Methylases - genetics | Brain Diseases - pathology | Aged | Index Medicus
Journal Article
STEM CELLS, ISSN 1066-5099, 01/2010, Volume 28, Issue 1, pp. 5 - 16
Cancer stem cells (CSCs) are thought to be critical for the engraftment and long‐term growth of many tumors, including glioblastoma (GBM). The cells are at... 
NOTCH | γ‐Secretase inhibitor | Cancer Stem Cell | Glioblastoma | Cancer stem cell | γ-Secretase inhibitor | CANCER-CELLS | INITIATING CELLS | EMBRYONAL BRAIN-TUMORS | SIDE POPULATION | SELF-RENEWAL | INTERSTITIAL CHEMOTHERAPY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | MALIGNANT GLIOMA | STEM-LIKE CELLS | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CENTRAL-NERVOUS-SYSTEM | HEMATOLOGY | gamma-Secretase inhibitor | Neurons - pathology | Glioblastoma - enzymology | Phosphorylation | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Brain Neoplasms - pathology | Glycoproteins - metabolism | Neoplastic Stem Cells - immunology | Receptor, Notch2 - genetics | Antigens, CD - metabolism | Dose-Response Relationship, Drug | Brain Neoplasms - immunology | Peptides - metabolism | Transfection | Time Factors | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Female | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Neurons - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Spheroids, Cellular | STAT3 Transcription Factor - metabolism | Brain Neoplasms - enzymology | Enzyme Inhibitors - pharmacology | Neurons - immunology | Receptor, Notch2 - metabolism | Tumor Burden | Brain Neoplasms - drug therapy | AC133 Antigen | Xenograft Model Antitumor Assays | Amyloid Precursor Protein Secretases - metabolism | Animals | Glioblastoma - immunology | Signal Transduction - drug effects | Mice, Nude | Glioblastoma - pathology | Neurons - enzymology | Cell Proliferation - drug effects | Mice | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Glioblastoma - drug therapy | Neoplastic Stem Cells - enzymology
Journal Article
Molecular Cell, ISSN 1097-2765, 01/2014, Volume 53, Issue 1, pp. 75 - 87
Journal Article
Cancer Cell, ISSN 1535-6108, 02/2016, Volume 29, Issue 2, pp. 201 - 213
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2013, Volume 110, Issue 21, pp. 8644 - 8649
Journal Article
Journal Article
STEM CELLS, ISSN 1066-5099, 05/2010, Volume 28, Issue 5, pp. 851 - 862
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2010, Volume 28, Issue 17, pp. 2817 - 2823
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/1999, Volume 5, Issue 5, pp. 1107 - 1113
Journal Article
Nature, ISSN 0028-0836, 2015, Volume 520, Issue 7547, pp. 363 - 367
Journal Article